It’s #CRISPR. Emmanuelle Charpentier and Jennifer Doudna ,who pioneered the revolutionary gene-editing technology, are the winners of this year’s #NobelPrize in Chemistry. #NobelPrize2020 go.nature.com/3jHfl68

In a woman with thyroid cancer expressing an EML4-NTRK3 fusion gene, the cancer had become refractory to radioactive iodine when the capacity of the tumors to take up iodine was lost.

Active surveillance for low-risk prostate CA appears comparably safe for Black vs White men in equitable care systems such as Veterans Affairs. Further reassurance would be gained from research showing similar outcomes in broader settings Curtis Pettaway, MD ja.ma/34R5VQw

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors | NEJM nejm.org/doi/10.1056/NE…

The findings of a recent study "indicate that nivolumab plus relatlimab should likely become the new standard of care in first-line advanced melanoma," according to our Dr. Hussein Tawbi: fal.cn/3fzV5 Healio Hussein Tawbi, MD, PhD #ASCO21 #melanoma #EndCancer

Just published! We proudly present "Hallmarks of Cancer: New Dimensions" by Douglas Hanahan, the third update to the seminal series. bit.ly/3GkSqZK Ludwig Cancer

Truly honored! Thank you Conquer Cancer, the ASCO Foundation Tap Cancer Out for this wonderful opportunity!

Got to attend my first in person #ASCO2022 with this stellar group! MD Anderson Cancer Center came to represent at the Conquer Cancer, the ASCO Foundation awards this year! More to come! Michael Nakazawa MD PhD Patrick Reville, MD, MPH AmyAn Dr. Ajlan Al Zaki الدكتور عجلان الزاكي Hua-Jay (Jeff) Cherng Andrew Jallouk Owhofasa Agbedia, MD, MPH, FACP.

What are the latest advances in treating sarcoma? Learn about the findings that our Dr. Neeta Somaiah and MD Anderson experts will be presenting at #ASCO23. fal.cn/3yM3T Neeta Somaiah, MD Anthony P Conley Michael Nakazawa MD PhD ASCO #Sarcoma #EndCancer

💫Poster Board 483 #sarcoma Superstar Michael Nakazawa MD PhD and Andy Livingston, MD MS presenting work from MD Anderson Cancer Center: Identification of a subset of DDR deficient #LMS with loss of RNase H2 ⚠️therapeutic implications ‼️potentially targetable